Palbociclib Hydrochloride-impurities | Pharmaffiliates

Palbociclib Hydrochloride

Palbociclib Hydrochloride, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. Reference standards of Palbociclib Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Palbociclib Hydrochloride - API Standards 
    [catalogue_number] => PA 16 3010000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 484
    [form] => C24H30ClN7O2
    [cas] => 827022-32-2
    [pslug] => 827022-32-2-palbociclib-hydrochloride-api-pa163010000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 16 3010000

Palbociclib Hydrochloride - API Standards


  • Catalogue No.:PA 16 3010000

  • CAS :

    827022-32-2

  • Molecular Formula : C24H30ClN7O2

  • Molecular Weight : 484